| Domain | Key points | Quantitative data | Evidence type | Key sources (with DOI/URL if available) |
|---|---|---|---|---|
| Identifiers | Explicit MeSH disease heading available: **Fluorosis, Dental**; related MeSH ancestors include **Dental Enamel Hypomineralization** and **Developmental Defects of Enamel**. Some trial records also map fluorosis-related concepts to **Fluoride Poisoning**. Synonym/descriptor noted in classic literature: **mottled enamel** / mottling of enamel. No explicit ICD-10/ICD-11, MONDO, or SNOMED CT identifiers were retrieved in the available evidence. | MeSH: **D009050** (Fluorosis, Dental); related MeSH: **D005458** (Fluoride Poisoning) | Registry metadata; review/classification literature | ClinicalTrials.gov-derived records (NCT05204277, NCT03746990, NCT05339503, NCT01589991) (pqac-00000022, pqac-00000023, pqac-00000024, pqac-00000026); Fejerskov et al. 1990, J Dent Res, DOI: https://doi.org/10.1177/00220345900690s135 (pqac-00000025) |
| Definition / overview | Dental fluorosis is a **developmental enamel defect** caused by **excess fluoride exposure during tooth development/odontogenesis**. It manifests as visible enamel changes ranging from faint white lines/opacities to chalky hypomineralized enamel and post-eruptive breakdown in severe cases. Most contemporary sources emphasize that fluorosis is usually mild/cosmetic, but severity rises with higher fluoride exposure. | Vulnerable developmental window reported as **~6 months to 4 years** in the Mexico systematic review; risk generally limited to children whose permanent teeth are still developing (often stated as up to about **8 years**). | Systematic review/meta-analysis; cross-sectional NHANES; classic mechanistic review | Gamarra et al. 2024, BMC Oral Health, DOI: https://doi.org/10.1186/s12903-024-04472-7 (pqac-00000000); Hung et al. 2023, JAMA Netw Open, DOI: https://doi.org/10.1001/jamanetworkopen.2023.18406 (pqac-00000002); Fejerskov et al. 1990, DOI: https://doi.org/10.1177/00220345900690s135 (pqac-00000010) |
| Main risk factors | Primary risk factor is **high fluoride intake during odontogenesis**, especially from **drinking water** in endemic areas. Other exposure sources summarized in recent review include **brick tea, coal-burning exposure, fluoridated foods/beverages, and toothpaste**. Severity is dose-related, and Northern Mexico shows higher severity where water fluoride is higher. | NHANES adjusted OR for fluorosis with water fluoride: **AOR 2.378** (95% CI 1.218–5.345) in one model; combined-cycle water fluoride **>0.70 mg/L AOR 2.790** (95% CI 1.582–5.249). Plasma fluoride **AOR 1.568** (95% CI 1.038–2.499); combined **AOR 1.659** (95% CI 1.154–2.430). Mexico meta-analysis: North region severe **TF ≥5 pooled estimate 4.78 [3.55, 6.42]**; West region **≤TF4 pooled estimate 0.01 [0.00, 0.52]**. | Cross-sectional nationally representative study; systematic review/meta-analysis; review | Hung et al. 2023, DOI: https://doi.org/10.1001/jamanetworkopen.2023.18406 (pqac-00000001, pqac-00000002, pqac-00000005); Gamarra et al. 2024, DOI: https://doi.org/10.1186/s12903-024-04472-7 (pqac-00000000); Zhang et al. 2023, DOI: https://doi.org/10.3389/fcell.2023.1168215 (pqac-00000012) |
| Epidemiology | Recent high-profile US data suggest fluorosis prevalence remains common among children/adolescents, though lower in 2015–2016 than 2013–2014. Regional endemic burdens remain substantial in high-fluoride water areas such as parts of Mexico. | NHANES weighted prevalence of any fluorosis: **87.3% (2013–2014)** and **68.2% (2015–2016)** among ages 6–15. Water fluoride means: **0.56 mg/L** (2013–2014) and **0.46 mg/L** (2015–2016). | Cross-sectional nationally representative survey; regional systematic review/meta-analysis | Hung et al. 2023, DOI: https://doi.org/10.1001/jamanetworkopen.2023.18406 (pqac-00000001, pqac-00000005); Gamarra et al. 2024, DOI: https://doi.org/10.1186/s12903-024-04472-7 (pqac-00000000) |
| Genetic susceptibility | Available human evidence supports **modifier/susceptibility genetics**, not a simple Mendelian cause. Recent Tunisian case-control data implicate **COL1A2 rs412777**. A recent review summarizes additional candidate loci/genes associated with susceptibility: **DLX1, DLX2, MMP13, TIMP1, TIMP2, AMBN, COL14A1, MMP20, AMELX, ESR1, SOD2, TFIP11, TUFT1**. | COL1A2 rs412777: A allele protective **OR 0.375** (95% CI 0.207–0.672; p=0.001). **AA genotype** protective in codominant model **OR 0.18** (95% CI 0.06–0.55; p=0.002) and dominant model **OR 0.19** (95% CI 0.07–0.52; p<0.001). Study size **95** (51 cases, 44 controls). | Human case-control genetics; narrative review of candidate-gene studies | Kallala et al. 2024, BMC Oral Health, DOI: https://doi.org/10.1186/s12903-024-04086-z (pqac-00000015, pqac-00000020); Zhang et al. 2023, DOI: https://doi.org/10.3389/fcell.2023.1168215 (pqac-00000014, pqac-00000016, pqac-00000017, pqac-00000018) |
| Gene–environment interaction | Genetics appears to modify susceptibility under shared fluoride exposure environments. The review literature cites interaction studies involving antioxidant genes and fluoride exposure, and Kallala notes prior literature supporting synergistic gene–environment effects. Formal GxE effect estimates were not available in the retrieved excerpts. | Qualitative only in retrieved excerpts; one review cites **SOD2/SOD3 × fluoride exposure** interaction studies without numerical estimates in the available text. | Review of genetic epidemiology; discussion in case-control study | Zhang et al. 2023, DOI: https://doi.org/10.3389/fcell.2023.1168215 (pqac-00000017, pqac-00000018); Kallala et al. 2024, DOI: https://doi.org/10.1186/s12903-024-04086-z (pqac-00000019) |
| Epigenetic / transcriptomic findings | Experimental evidence indicates dental fluorosis involves broad transcriptomic and epigenetic dysregulation. Rat molar profiling identified **Atp2c1** and **Nr1d1** as key genes linked to **Ca2+ transport, ER stress, and immune regulation**; pathways included ion transport, cytokine signaling, NOD-like receptor signaling, and NF-κB-related immune signaling. Specific DNA methylation changes were reported in multiple genes. | **1,723 DEGs** (1,050 up, 673 down); **2,511 DE-lncRNAs** (1,507 up, 1,004 down); **67 significant KEGG pathways**; targeted methylation across **409 CpGs/17 genes**, with **13 CpG sites** significantly changed. | Animal model multi-omics (RNA-seq + targeted methylation) | Hu et al. 2024, Biol Trace Elem Res, DOI: https://doi.org/10.1007/s12011-023-03660-w (pqac-00000008, pqac-00000009) |
| Mechanism / pathophysiology | Current mechanistic understanding centers on **ameloblast stress biology**: excessive fluoride can induce **ER stress**, disturb **Ca2+ homeostasis**, increase **oxidative stress/ROS**, alter **autophagy**, reduce **KLK4/MMP20** synthesis or secretion, and promote **ameloblast apoptosis**, impairing enamel matrix removal and maturation and leading to porous hypomineralized enamel. | Retrieved mechanistic papers provide mainly qualitative mechanistic evidence; no single unifying human effect estimate available. | Review; in vitro ameloblast studies; animal multi-omics | Zhang et al. 2023, DOI: https://doi.org/10.3389/fcell.2023.1168215 (pqac-00000011, pqac-00000012); Wei et al. 2013, DOI: https://doi.org/10.1002/tox.20724; Zhang et al. 2016, DOI: https://doi.org/10.1016/j.archoralbio.2016.05.015; Suzuki et al. 2015, DOI: https://doi.org/10.1016/j.freeradbiomed.2015.08.015 (mechanistic papers listed in conversation) |
| Diagnostic indices | The main clinical indices identified were **Dean’s Index** and the **Thylstrup–Fejerskov (TF) index**. Dean’s index remains historically dominant and simple; TF is considered more biologically valid and correlates better with histopathology/enamel fluoride. A simplified TF using six upper anterior teeth performed well in endemic settings. | Simplified TF performance: **Sensitivity 90.6%** (95% CI 86.6–93.6), **Specificity 100%** (95% CI 95.3–100), **PPV 100%**, **NPV 77.5%** (95% CI 69.8–83.5), **ROC 0.953** (95% CI 0.933–0.973). | Methods/validation studies; classic review; current systematic review | Adelario et al. 2010, Int J Environ Res Public Health, DOI: https://doi.org/10.3390/ijerph7030927; Rozier 1994, DOI: https://doi.org/10.1177/08959374940080010901 (pqac-00000013); Fejerskov et al. 1990, DOI: https://doi.org/10.1177/00220345900690s135 (pqac-00000010); Gamarra et al. 2024, DOI: https://doi.org/10.1186/s12903-024-04472-7 (pqac-00000000) |
| Clinical / public-health implications | Public-health decisions must balance **caries prevention benefits** of fluoride against **fluorosis risk**. Recent US and English data reinforce that fluoride remains protective for caries while higher systemic exposure raises fluorosis odds. Reviews and position statements argue for **optimized**, not indiscriminate, fluoride use. | England ecological study: compared with <0.2 mg/L, CWF prevented **17%–28%** of caries across SES groups and **56%** of dental extractions. NHANES fluorosis odds increased with higher water/plasma fluoride; supplement use was not significantly associated in the retrieved NHANES analysis. | Ecological study; national cross-sectional study; policy statement | Roberts et al. 2023, J Public Health, DOI: https://doi.org/10.1093/pubmed/fdac066; Hung et al. 2023, DOI: https://doi.org/10.1001/jamanetworkopen.2023.18406 (pqac-00000001, pqac-00000002); Lee et al. 2025, DOI: https://doi.org/10.18332/popmed/200818 |
| Treatment trials / implementations | Evidence in the conversation identifies minimally invasive esthetic management strategies: **microabrasion**, **in-office bleaching**, **remineralization/CPP-ACFP (MI-Paste Plus)**, **resin infiltration**, and combinations of these. These are used mainly for **mild–moderate** fluorosis. | **NCT01733888**: resin infiltration ± bleaching for fluorosis stains, pediatric population, enrollment **80**. **NCT05204277**: microabrasion (6.6% HCl + silicon carbide), in-office bleaching, MI-Paste Plus; enrollment **16**. **NCT05051748**: 8 minimally invasive protocols including Opalescence Boost 40%, Opalustre microabrasion, MI-Paste Plus; **160 fluorosed teeth**, follow-up to **6 months**. **NCT05339503**: microabrasion compounds comparison; enrollment **60**. | Interventional clinical trials / registry records | ClinicalTrials.gov NCT01733888 (pqac-00000007, pqac-00000021); NCT05204277 (pqac-00000003, pqac-00000022); NCT05051748 (pqac-00000004, pqac-00000006); NCT05339503 (pqac-00000024) |
| Evidence gaps | No explicit MONDO/ICD/SNOMED identifiers were found in the retrieved evidence. Genetic findings remain heterogeneous and mostly from candidate-gene studies; strong replication and robust formal GxE analyses are limited in the available excerpts. Mechanistic evidence is richer in cell/animal models than in human tissue studies. | Not applicable | Synthesis across retrieved evidence | Based on retrieved sources only (pqac-00000014, pqac-00000016, pqac-00000017, pqac-00000018, pqac-00000021, pqac-00000022, pqac-00000025) |


*Table: This table summarizes the key knowledge-base fields for dental fluorosis using only evidence retrieved in the conversation. It highlights identifiers, epidemiology, mechanisms, genetics, diagnostic indices, and current treatment/public-health evidence with traceable source citations.*